These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Components of the fibrinolytic system in the vitreous body in patients with vitreoretinal disorders. Ulrich JN; Spannagl M; Kampik A; Gandorfer A Clin Exp Ophthalmol; 2008 Jul; 36(5):431-6. PubMed ID: 18939350 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1. Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous. Takano A; Hirata A; Inomata Y; Kawaji T; Nakagawa K; Nagata S; Tanihara H Am J Ophthalmol; 2005 Oct; 140(4):654-60. PubMed ID: 16140249 [TBL] [Abstract][Full Text] [Related]
11. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Asami T; Terasaki H; Kachi S; Nakamura M; Yamamura K; Nabeshima T; Miyake Y Ophthalmology; 2004 Feb; 111(2):231-7. PubMed ID: 15019368 [TBL] [Abstract][Full Text] [Related]
12. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome. Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792 [TBL] [Abstract][Full Text] [Related]
15. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane. Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764 [TBL] [Abstract][Full Text] [Related]
16. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Agren A; Wiman B; Schulman S Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. Glas-Greenwalt P; Kant KS; Allen C; Pollak VE J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000 [TBL] [Abstract][Full Text] [Related]
19. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy. Qian J; Lu Q; Tao Y; Jiang YR Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241 [TBL] [Abstract][Full Text] [Related]
20. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity. Pawlak K; Pawlak D; Mysliwiec M Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]